Use of daclizumab in the immunosuppression of high-risk kidney and kidney/pancreas recipients: Warsaw transplantation center experience

Author: Baczkowska T.   Kukula K.   Nowacka-Cieciura E.   Cieciura T.   Lewandowska D.   Ciecierski R.   Grochowiecki T.   Rowinski W.   Szmidt J.   Durlik M.   Lao M.  

Publisher: Elsevier

ISSN: 0041-1345

Source: Transplantation Proceedings, Vol.34, Iss.2, 2002-03, pp. : 551-552

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content